Retail Giant AS Watson Eyes Major Move into Australian Market with Potential $500M Pharmacy Acquisition
In this article (4)
AS Watson, a Hong Kong-based health and beauty retailer, is potentially planning a move into the Australian market. The company is believed to be considering an acquisition of over 90 pharmacies in Australia.
Expansion into Australia
The company’s interest is reportedly focused on 92 Priceline pharmacies, previously under the operation of Infinity Pharmacy Group. This move will represent AS Watson’s debut into the Australian market. The company is said to be planning a comprehensive review of these pharmacies, which indicates serious intent towards the acquisition.
It is suggested that executives from AS Watson had visited Australia several years prior and had discussions with the founding partner of Infinity. These visits may well have laid the groundwork for the current acquisition proposal. However, a spokesperson for the group declined to provide any comment on these market speculations.
The Players Involved
AS Watson is a part of CK Hutchison Holdings – a major commercial conglomerate based in Hong Kong. On the other side of the equation, the Priceline brand is owned by Australian conglomerate, Wesfarmers, while Infinity Pharmacy Group functions as a franchisee of the chain.
In a recent development, Wesfarmers placed approximately half of Infinity’s stores into receivership, following a period of enduring financial difficulties. These financial struggles have led to the sale of the 92 Priceline stores, managed by Infinity’s administrator, Teneo.
The Sale Process
Teneo, responsible for the administration of the sale process, is said to be seeking a minimum sale price of AU$500 million for these 92 Priceline stores.
Questions & Answers
What is the significance of this potential acquisition by AS Watson?
The acquisition could mark AS Watson’s entry into the Australian market, expanding its global footprint.
Who currently owns the Priceline brand and the affected pharmacies?
The Priceline brand is owned by Wesfarmers, an Australian conglomerate. The affected pharmacies were previously operated by Infinity Pharmacy Group, a franchisee of the chain.
What is the expected price for the sale of these 92 Priceline stores?
The administrator overseeing the sale, Teneo, is reportedly seeking a minimum price of AU$500 million for the stores.